CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16493 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Quan Pan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA. Hauptthemen laut MEDLINE: Smad3 Protein, Glucagon, Liver, Ubiquitin-Protein Ligases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Institute of Food and Agriculture, NIDDK NIH HHS, American Diabetes Association.
Abstract (Originalsprache)
Aims
Excessive hepatic glucose production (HGP) driven by glucagon contributes to hyperglycaemia in obesity and type 2 diabetes (T2D), yet the molecular mechanisms underlying this dysregulation remain incompletely defined. This study investigates the role of Smad3 signaling and its regulation by CHIP (Carboxy‐terminus of Hsc70‐interacting protein) in modulating glucagon action on HGP. Materials and Methods We examined glucagon signaling and HGP in primary hepatocytes and in high‐fat diet (HFD)‐induced obese (DIO) mice. Mechanistic studies included hepatic knockdown of CHIP and Smad3, assessment of Smad3 protein stability, ubiquitination assays, and quantification of gluconeogenic gene expression.
Results
We identified Smad3 as a key mediator of glucagon‐induced HGP, synergizing with TGF‐β1 signaling to enhance gluconeogenic gene G6pc expression in a Foxo1‐dependent manner. Glucagon elevated Smad3 protein levels by inhibiting CHIP‐mediated ubiquitination, thereby increasing Smad3 stability. CHIP expression was downregulated in the livers of DIO mice. Hepatic CHIP knockdown augmented glucagon‐stimulated HGP and increased Smad3 levels, whereas simultaneous knockdown of Smad3 reversed these effects.
Conclusions
Our findings reveal a novel CHIP–Smad3 regulatory axis that enhances glucagon action on HGP in obesity. Targeting this pathway may offer a new therapeutic strategy for improving glycaemic control in T2D.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition, College of Agriculture and Life Sciences, Texas A&M University, College Station, Texas, USA.
ORCID-Profile: Quan Pan
Förderung
- National Institute of Food and Agriculture
- NIDDK NIH HHS
- American Diabetes Association
- College of Agriculture and Life Sciences, Texas A and M University, Faculty Start-up funds
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Pan, Q., Ai, W., Chen, Y., Shen, Z., Yang, W., Jiang, W., & Guo, S. (2025). CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16493
Vancouver
Pan Q, Ai W, Chen Y, Shen Z, Yang W, Jiang W, et al. CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16493
BibTeX
@article{Pan2025,
author = {Pan, Quan and Ai, Weiqi and Chen, Yunmei and Shen, Zheng and Yang, Wanbao and Jiang, Wen and Guo, Shaodong},
title = {CHIP mediates glucagon action on hepatic glucose production via regulating Smad3 ubiquitination},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16493}
}
EUVIMED